Evidence map›Paper›PMID 42817640›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2026

Proteostasis and ageing dissidence.

Neethu Babu, Katie Whalen, Brian Freeman

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neethu BabuCell and Developmental Biology, University of Illinois at Urbana-Champaign , Urbana, IL 61801, USA.
Katie WhalenCell and Developmental Biology, University of Illinois at Urbana-Champaign , Urbana, IL 61801, USA.
Brian FreemanCell and Developmental Biology, University of Illinois at Urbana-Champaign , Urbana, IL 61801, USA.ORCID 0000-0003-0851-5423

Funding

Regulation of the Native Protein Landscape in the Nucleus by Molecular ChaperonesR35GM136660 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Brian C Freeman · 2020 to 2026
$2.7M
NIGMS NIH HHS R35 GM136660
6 · The paper itself

Abstract

Proteostasis, the process governing the dynamic regulation of protein synthesis, folding and degradation, is critical for maintaining cell function and organismal health. Ageing disrupts this intricate system, leading to inactive, misfolded and/or aggregated proteins that contribute to age-associated pathologies. Here, we explore current findings on proteostasis and its deterioration during ageing with an attention to three major pathways: molecular chaperone (MC), ubiquitin-proteasome system (UPS) and autophagy-lysosomal pathway. Components in all three paths undergo age-dependent decline in both expression and function, with each impairment having select initial outcomes on the health of a proteome. For example, loss in the MC path may cause nascent chain defects, whereas a decline in the UPS may result in the accumulation of toxic aggregates. Notably, the interconnectedness of these pathways results in reciprocal reactions in all three. Understanding how each path connects to the others and how these connections are regulated offers promising strategies to restore proteome integrity and extend a healthy lifespan. This article is part of the Theo Murphy meeting issue 'ProteostaSys: a systems view of proteostasis'.

Indexed as

AgingAutophagyProteostasisAnimalsHumansMolecular ChaperonesProteasome Endopeptidase ComplexUbiquitinMolecular ChaperonesProteasome Endopeptidase ComplexUbiquitinageingautophagy–lysosome pathwaymolecular chaperoneproteostasisubiquitin–proteasome system

Identifiers

PMID42817640
PMCPMC13628051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.